Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|October 1, 2015
Risk Analysis of Pneumonitis in Taxane Therapy After Chemoradiotherapy for Patients With Metastatic or Recurrent Esophageal CancerYoshihiro Kishida, Takahiro Tsushima, Masahiro Endo, et al.
Japanese Journal of Clinical Oncology|March 2, 2010
S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failureAkiko Todaka, Akira Fukutomi, Narikazu Boku, et al.
Journal of Gastroenterology|November 18, 2008
Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancerKoichi Taira, Narikazu Boku, Akira Fukutomi, et al.
Investigational New Drugs|July 28, 2022
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort studySae Ohwada, Akiko Todaka, Hiroshi Nakase, et al.
International Journal of Clinical Oncology|May 9, 2008
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinumKentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|April 22, 2017
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3Masahiro Kawahira, Tomoya Yokota, Satoshi Hamauchi, et al.
Investigational New Drugs|March 15, 2012
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumoursYasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, et al.
International Journal of Clinical Oncology|March 7, 2013
Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?Tomoya Yokota, Tetsuro Onitsuka, Kimihide Kusafuka, et al.
Japanese Journal of Clinical Oncology|February 29, 2012
Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation studyYoshinori Ito, Mitsukuni Suenaga, Kiyohiko Hatake, et al.
Japanese Journal of Clinical Oncology|March 11, 2008
Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trialMasaru Narabayashi, Yasuo Saijo, Seiichi Takenoshita, et al.
Pageof 11